Jan Wagner1, Juri-Alexander Witt2, Christoph Helmstaedter2, Michael P Malter3, Bernd Weber4, Christian E Elger4. 1. Department of Epileptology, University of Bonn, Bonn, Germany Department of NeuroCognition/Imaging, Life & Brain Center, Bonn, Germany. 2. Department of Epileptology, University of Bonn, Bonn, Germany. 3. Department of Epileptology, University of Bonn, Bonn, Germany Department of Neurology, Marien-Krankenhaus, Bergisch Gladbach, Germany. 4. Department of Epileptology, University of Bonn, Bonn, Germany Department of NeuroCognition/Imaging, Life & Brain Center, Bonn, Germany Center for Economics and Neuroscience, University of Bonn, Bonn, Germany.
Abstract
OBJECTIVE: Limbic encephalitis (LE) is an autoimmune mediated disease leading to temporal lobe epilepsy, mnestic and psychiatric symptoms. In recent years, several LE subforms defined by serum antibody findings have been described. MRI usually shows volume changes of the amygdala and hippocampus. However, studies quantifying longitudinal volume changes in the acute disease stage are lacking. METHODS: The aim of this retrospective observational study was to evaluate and quantify these volume changes by applying a fully automated volumetric approach to serial MRIs of 28 patients with antibody-associated LE. The results were compared with those of 28 age-matched and gender-matched healthy controls and analysed separately for the different antibody profiles and correlated with clinical parameters. Antibody profile analyses were exploratory due to the relatively small sample sizes. RESULTS: We found distinct volumetric and clinical courses depending on the associated antibody. While LE associated with voltage-gated potassium channel-complex antibodies (VGKC-LE) showed highly significant larger volumes of both the amygdala and the hippocampus within the first 12 months after disease onset, LE associated with glutamic acid decarboxylase antibodies (GAD-LE) only displayed greater amygdala volumes at this disease stage. Both subgroups showed a reduction of the amygdala and hippocampus volumes during follow-up with higher volume changes in VGKC-LE. CONCLUSIONS: These differences in the volumetric evolution corresponded to distinct clinical courses in terms of a more severe initial symptomatology regarding seizure, mnestic and psychiatric disturbances in VGKC-LE, which improved rapidly, corresponding to the evolution of the volumetric changes. In contrast to this, patients with GAD-LE were less severely affected at disease onset, showing a more unmodulated and chronic disease course during follow-up. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: Limbic encephalitis (LE) is an autoimmune mediated disease leading to temporal lobe epilepsy, mnestic and psychiatric symptoms. In recent years, several LE subforms defined by serum antibody findings have been described. MRI usually shows volume changes of the amygdala and hippocampus. However, studies quantifying longitudinal volume changes in the acute disease stage are lacking. METHODS: The aim of this retrospective observational study was to evaluate and quantify these volume changes by applying a fully automated volumetric approach to serial MRIs of 28 patients with antibody-associated LE. The results were compared with those of 28 age-matched and gender-matched healthy controls and analysed separately for the different antibody profiles and correlated with clinical parameters. Antibody profile analyses were exploratory due to the relatively small sample sizes. RESULTS: We found distinct volumetric and clinical courses depending on the associated antibody. While LE associated with voltage-gated potassium channel-complex antibodies (VGKC-LE) showed highly significant larger volumes of both the amygdala and the hippocampus within the first 12 months after disease onset, LE associated with glutamic acid decarboxylase antibodies (GAD-LE) only displayed greater amygdala volumes at this disease stage. Both subgroups showed a reduction of the amygdala and hippocampus volumes during follow-up with higher volume changes in VGKC-LE. CONCLUSIONS: These differences in the volumetric evolution corresponded to distinct clinical courses in terms of a more severe initial symptomatology regarding seizure, mnestic and psychiatric disturbances in VGKC-LE, which improved rapidly, corresponding to the evolution of the volumetric changes. In contrast to this, patients with GAD-LE were less severely affected at disease onset, showing a more unmodulated and chronic disease course during follow-up. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: H Urbach; S Rauer; I Mader; S Paus; J Wagner; M P Malter; H Prüss; J Lewerenz; J Kassubek; H Hegen; M Auer; F Deisenhammer; F Ufer; C G Bien; A Baumgartner Journal: Neuroradiology Date: 2015-08-21 Impact factor: 2.804
Authors: L Ernst; B David; J Gaubatz; I Domínguez-Narciso; G Lüchters; A J Becker; B Weber; E Hattingen; C E Elger; T Rüber Journal: AJNR Am J Neuroradiol Date: 2019-11-14 Impact factor: 3.825
Authors: Thomas D Miller; Trevor T-J Chong; Anne M Aimola Davies; Michael R Johnson; Sarosh R Irani; Masud Husain; Tammy Wc Ng; Saiju Jacob; Paul Maddison; Christopher Kennard; Penny A Gowland; Clive R Rosenthal Journal: Elife Date: 2020-01-24 Impact factor: 8.140
Authors: Christoph Mueller; Lisa Langenbruch; Johanna M H Rau; Tobias Brix; Christine Strippel; Andre Dik; Kristin S Golombeck; Constanze Mönig; Andreas Johnen; Saskia Räuber; Heinz Wiendl; Sven G Meuth; Jens Bölte; Stjepana Kovac; Nico Melzer Journal: Arch Clin Neuropsychol Date: 2022-05-16 Impact factor: 3.448
Authors: Olga Schröder; Elisabeth Schriewer; Kristin S Golombeck; Julia Kürten; Hubertus Lohmann; Wolfram Schwindt; Heinz Wiendl; Maximilian Bruchmann; Nico Melzer; Thomas Straube Journal: Front Neurol Date: 2015-11-30 Impact factor: 4.003